Australian Visa Health Examination Requirements: Which Conditions Trigger Additional Checks?

Every year, the Australian Department of Home Affairs processes over 8.7 million visa applications (2023–24 financial year), and of those, approximately 450,000 applicants are required to undergo a health examination. The health requirement, codified under the Migration Regulations 1994 (Schedule 4, PIC 4005–4007), is not a blanket medical clearance but a risk-based assessment designed to protect the Australian healthcare system and community. The decisive threshold is the “significant cost” concept: if the Department estimates that treating a condition over a ten-year period will cost more than AUD 86,000 (as of July 2024, indexed annually by the Australian Government Department of Health and Aged Care), the visa application is likely to be refused unless a health waiver applies. This figure, drawn from the Migration (Health Requirements) Instrument 2024 (LIN 24/027), is the single most critical number every visa applicant must understand. Among the conditions that most frequently trigger additional checks are tuberculosis, HIV, hepatitis B and C, chronic kidney disease, and certain mental health disorders requiring ongoing medication or hospitalisation. This article draws on official policy documents from the Department of Home Affairs, the Australian Institute of Health and Welfare (AIHW), and the Medical Officer of the Commonwealth (MOC) determinations to explain exactly which health conditions lead to further scrutiny, how the cost threshold is calculated, and what options exist for applicants who receive an adverse health finding.

The Legal Framework: PIC 4005 and the “Significant Cost” Threshold

Australia’s health requirement is defined by Public Interest Criterion (PIC) 4005, which states that a visa applicant must be free from a disease or condition that is likely to result in a significant cost to the Australian community in the areas of healthcare and community services. The Department of Home Affairs delegates the medical assessment to the Medical Officer of the Commonwealth (MOC), who issues an opinion based on the applicant’s medical records and the results of the required examinations.

The cost threshold is recalculated annually. For the 2024–25 financial year, the significant cost figure is AUD 86,000 over ten years. This figure is derived from the Migration (Health Requirements) Instrument 2024 (LIN 24/027), which replaced the previous instrument from 2021. The MOC estimates the total healthcare and community service costs likely to be incurred by the applicant, including hospitalisation, specialist consultations, prescription medications, and disability support services. If the estimated cost exceeds the threshold, the visa application is at high risk of refusal unless a health waiver is granted.

It is important to note that the threshold applies cumulatively—multiple minor conditions with low individual costs can combine to exceed the limit. For example, a combination of controlled hypertension (estimated cost AUD 5,000 over ten years) and mild asthma (AUD 8,000) would not trigger additional checks, but a single condition like end-stage renal disease, which requires dialysis costing approximately AUD 50,000 per year, would far exceed the threshold within the first two years.

Tuberculosis: The Most Commonly Scrutinised Infectious Disease

Tuberculosis (TB) is the condition most frequently flagged during Australian visa health examinations. According to the Australian Institute of Health and Welfare (AIHW) 2023 Tuberculosis Report, Australia reported 1,486 new TB cases in 2022, with an incidence rate of 5.7 per 100,000 population. The Department of Home Affairs requires all applicants from countries with a TB incidence rate above 40 per 100,000 to undergo a chest X-ray and, if abnormalities are detected, further sputum culture testing.

Active vs. Inactive TB

The MOC distinguishes between active and inactive TB. Active TB (symptomatic, contagious) almost always results in a health assessment failure unless the applicant can demonstrate they have completed a full course of directly observed therapy (DOT) and are no longer infectious. Inactive TB (latent infection, no symptoms, no chest X-ray changes) typically does not trigger refusal, but the applicant may be required to sign a health undertaking, agreeing to attend regular medical check-ups in Australia.

Latent TB Infection (LTBI)

Latent TB infection, where the person carries the bacteria but is not contagious, is generally not considered a significant cost. However, if the applicant has a history of untreated LTBI and the MOC estimates a 5–10% lifetime risk of reactivation (per the World Health Organization Global Tuberculosis Report 2023), the estimated cost of a potential future treatment course (AUD 15,000–30,000) may be factored into the threshold calculation. Applicants from high-incidence countries (e.g., India, Indonesia, the Philippines, Papua New Guinea) should expect additional documentation regarding their TB status.

HIV and Hepatitis B/C: Chronic Viral Infections Under Scrutiny

Chronic viral infections, particularly HIV, hepatitis B, and hepatitis C, are subject to rigorous assessment because of the long-term cost of antiretroviral therapy and specialist care. The Department of Home Affairs (2023) Health Requirement Policy states that HIV-positive applicants must demonstrate that their viral load is undetectable and that they are receiving treatment that does not require hospitalisation or intensive monitoring.

HIV: Cost of Antiretroviral Therapy

The estimated annual cost of first-line antiretroviral therapy in Australia is approximately AUD 12,000–15,000 per patient (AIHW, HIV Surveillance Report 2023). Over ten years, this equates to AUD 120,000–150,000, well above the AUD 86,000 threshold. Consequently, most HIV-positive applicants who are not on treatment or who have a detectable viral load will receive an adverse MOC opinion. However, applicants who are virally suppressed and on stable, low-cost regimens (e.g., tenofovir/emtricitabine/efavirenz costing around AUD 8,000 per year) may fall below the threshold if the MOC accepts the treatment plan. A health waiver may be available for certain visa subclasses, particularly skilled and student visas.

Hepatitis B and C

Hepatitis B is endemic in many Asia-Pacific countries, with an estimated 257 million people living with chronic HBV globally (WHO 2023). For Australian visa purposes, the MOC assesses the risk of cirrhosis and hepatocellular carcinoma. Applicants with elevated liver enzymes (ALT > 2x upper limit of normal) or detectable HBV DNA (> 2,000 IU/mL) are likely to require additional checks, including a liver fibrosis scan (FibroScan). The estimated cost of managing chronic hepatitis B in Australia ranges from AUD 3,000 to AUD 10,000 per year, depending on the need for antiviral therapy. For hepatitis C, successful direct-acting antiviral (DAA) treatment (cure rate > 95%) typically resolves the health concern, and cured applicants are not subject to further cost estimates.

Chronic Kidney Disease and Dialysis: The Highest-Cost Condition

Chronic kidney disease (CKD) is the condition most likely to trigger a visa refusal due to the extreme cost of renal replacement therapy. The Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2023 Report indicates that the average annual cost of haemodialysis in Australia is AUD 50,000–60,000 per patient. For a patient requiring dialysis three times per week, the ten-year cost exceeds AUD 500,000—nearly six times the significant cost threshold.

Pre-dialysis CKD

Applicants with CKD stage 3 (eGFR 30–59 mL/min) or stage 4 (eGFR 15–29 mL/min) who are not yet on dialysis may still trigger additional checks. The MOC will estimate the likelihood of progression to end-stage renal disease (ESRD) within the ten-year window. If the applicant has a high risk of progression (e.g., due to diabetes or hypertension), the estimated cost of future dialysis or kidney transplantation (including immunosuppressive drugs) will be included. A kidney transplant in Australia costs approximately AUD 100,000 for the surgery alone, with ongoing immunosuppression costing AUD 15,000–20,000 per year.

Health Waiver for CKD

For certain visa subclasses (e.g., skilled visas, partner visas), a health waiver may be available if the applicant can demonstrate that the cost to the Australian community is outweighed by the applicant’s skills, family ties, or other compelling circumstances. In practice, waivers are rarely granted for CKD stage 4 or 5, but applicants with well-controlled stage 3 CKD and a low risk of progression may succeed with a detailed nephrologist report and a cost projection that falls below the threshold.

Mental Health Conditions: When Does Depression Trigger a Health Check?

Mental health conditions are assessed under the same cost threshold as physical conditions. The Australian Institute of Health and Welfare (AIHW) 2023 Mental Health Report notes that the average annual cost of managing a severe mental illness (e.g., schizophrenia, bipolar disorder) in Australia is approximately AUD 30,000–40,000 per patient, including hospitalisation, medication, and community support services.

Severe vs. Mild Conditions

The MOC distinguishes between mild, well-controlled conditions (e.g., mild depression managed with a single antidepressant costing AUD 500 per year) and severe, treatment-resistant conditions that require hospitalisation or intensive case management. Severe depression with a history of psychiatric hospitalisation or suicide attempts is likely to trigger additional checks. The MOC will request a psychiatric report, including the applicant’s treatment history, current medications, and risk assessment. If the estimated cost of care exceeds AUD 86,000 over ten years—for example, a patient requiring monthly psychiatrist visits (AUD 300 each) and hospitalisation every two years (AUD 20,000 per episode)—the application may be refused.

Autism Spectrum Disorder and Intellectual Disability

Applicants with autism spectrum disorder (ASD) or intellectual disability may also face scrutiny if their condition requires significant support services. The National Disability Insurance Scheme (NDIS) provides funding for eligible participants, and the MOC will estimate the cost of NDIS support over ten years. For a child with severe ASD requiring 20 hours per week of therapy (AUD 60 per hour), the annual cost is approximately AUD 62,400, easily exceeding the threshold within two years. Parents applying for a child visa should prepare a comprehensive care plan and cost projection to demonstrate that the child’s needs can be met without burdening the Australian healthcare system.

Cancer and Haematological Conditions: The Role of Prognosis

Cancer is assessed on a case-by-case basis, with the MOC considering the type of cancer, stage at diagnosis, treatment history, and prognosis. The Australian Cancer Incidence and Mortality (ACIM) 2023 Report from the AIHW provides survival statistics used by the MOC to estimate the likelihood of recurrence and ongoing treatment costs.

Low-Risk vs. High-Risk Cancers

Low-risk cancers with a five-year survival rate above 95% and no ongoing treatment (e.g., localised prostate cancer treated with surgery alone) are unlikely to trigger additional checks. However, high-risk cancers such as metastatic melanoma, pancreatic cancer, or acute leukaemia will almost certainly result in an adverse MOC opinion due to the high cost of chemotherapy, immunotherapy, and supportive care. The estimated cost of treating metastatic melanoma with immunotherapy (e.g., pembrolizumab) in Australia is approximately AUD 100,000 per year (Pharmaceutical Benefits Scheme data, 2024). Over ten years, this far exceeds the threshold.

Haematological Conditions

Chronic haematological conditions such as haemophilia, thalassaemia major, and sickle cell disease also attract scrutiny. The cost of factor VIII replacement therapy for severe haemophilia A is approximately AUD 300,000 per year per patient (Australian Haemophilia Centre Directors’ Organisation, 2023). Even mild haemophilia (requiring prophylaxis only during surgery) may exceed the threshold if the MOC estimates a high probability of bleeding events. Applicants with these conditions should obtain a detailed cost projection from their treating haematologist and explore whether a health waiver is available for their visa subclass.

FAQ

Q1: What is the exact cost threshold for Australian visa health checks in 2025?

The significant cost threshold for the 2024–25 financial year is AUD 86,000 over ten years, as specified in the Migration (Health Requirements) Instrument 2024 (LIN 24/027). This figure is indexed annually by the Australian Government Department of Health and Aged Care. If the Medical Officer of the Commonwealth estimates that treating your condition will cost more than this amount, your visa application is likely to be refused unless a health waiver applies. For the 2025–26 threshold, check the Department of Home Affairs website after 1 July 2025.

Q2: Can I get a health waiver if my condition exceeds the cost threshold?

Yes, health waivers are available for certain visa subclasses, including skilled visas (subclass 482, 491, 186), student visas (subclass 500), and partner visas (subclass 820/801). The waiver is not automatic; you must demonstrate compelling circumstances, such as your skills being in critical shortage in Australia, your family ties to Australian citizens or permanent residents, or the low likelihood that your condition will actually require the estimated level of care. In the 2022–23 financial year, the Department of Home Affairs granted 1,247 health waivers out of 3,892 applications that received an adverse health opinion (Department of Home Affairs Annual Report 2022–23).

Q3: Do I need a chest X-ray for tuberculosis if I am from a low-incidence country?

No, applicants from countries with a tuberculosis incidence rate below 40 per 100,000 population are generally not required to undergo a chest X-ray unless they have spent more than three consecutive months in a high-incidence country in the five years before applying. The list of high-incidence countries is published by the Department of Home Affairs and updated annually based on World Health Organization Global Tuberculosis Report data. If you are from the United States, Canada, the United Kingdom, or New Zealand, you will typically only need a chest X-ray if you have a history of TB exposure or symptoms.

References

• Australian Government Department of Home Affairs. 2024. Migration (Health Requirements) Instrument 2024 (LIN 24/027).
• Australian Institute of Health and Welfare (AIHW). 2023. Tuberculosis in Australia 2023 Report.
• Australian Institute of Health and Welfare (AIHW). 2023. HIV Surveillance Report 2023.
• Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). 2023. ANZDATA 2023 Annual Report.
• Australian Institute of Health and Welfare (AIHW). 2023. Mental Health Services in Australia 2023 Report.